Providers & Payors
Collaborative Communities: Teaming Up with FDA to Solve Shared Challenges
Collaborative Communities are designed to bring together patients, providers, industry, regulators, payors, and other key medical device stakeholders in an open environment to tackle broad challenges, where each member has an equal voice. To date, FDA participates in six of them; MDIC’s Case for Quality Collaborative Community is the latest addition.
Read Article